AlphaCrest Capital Management’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,853
Closed -$478K 1405
2021
Q4
$478K Sell
26,853
-31,473
-54% -$650K 0.02% 1111
2021
Q3
$1.21M Sell
58,326
-486
-0.8% -$11.7K 0.06% 529
2021
Q2
$2.04M Sell
58,812
-7,837
-12% -$164K 0.09% 363
2021
Q1
$1.16M Buy
66,649
+55,013
+473% +$1M 0.06% 432
2020
Q4
$207K Sell
11,636
-764
-6% -$12.6K 0.02% 1071
2020
Q3
$192K Buy
+12,400
New +$219K 0.02% 1046
2019
Q3
Sell
-13,097
Closed -$91K 1338
2019
Q2
$91K Buy
+13,097
New +$92.8K 0.01% 996
2019
Q1
Sell
-17,433
Closed -$172K 951
2018
Q4
$172K Buy
+17,433
New +$181K 0.05% 603

Other funds holding SWBI

AlphaCrest Capital Management's SWBI Position: Q1 2022 in Review

AlphaCrest Capital Management sold out of Smith & Wesson (SWBI) in Q1 2022, closing a stake of 26,853 shares — an estimated $478K sold.

AlphaCrest Capital Management first reported a position in SWBI in Q4 2018 and held it in 8 quarters. The position peaked at $2.04M in Q2 2021. 223 funds tracked by Wall St. Rank hold SWBI as of Q1 2022.

  • AlphaCrest Capital Management reported no remaining Smith & Wesson position as of Q1 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 26,853 Smith & Wesson shares in Q1 2022, an estimated $478K.
  • AlphaCrest Capital Management first reported a position in Smith & Wesson in Q4 2018 and held it in 8 quarters.
  • AlphaCrest Capital Management's Smith & Wesson position peaked at $2.04M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2022.

Based on AlphaCrest Capital Management's 13F filing for Q1 2022, filed 12 May 2022.